Continous oral plus topical 5-ASA administration significantly modifies the clinical course of ulcerative colitis

Pimpo, Mariaterasa Mt; Galletti, B.; Latella, Giovanni; Chiaramonte, M.; Caprilli, R.; Frieri, G.

doi:10.1016/s0016-5085(08)80059-5

Gastroenterology

2001

DOI: 10.1016/s0016-5085(08)80059-5

|View full text |Cite

Continous oral plus topical 5-ASA administration significantly modifies the clinical course of ulcerative colitis

Mariaterasa Mt Pimpo¹,

B. Galletti²,

Giovanni Latella³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2002

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Update in Medical Therapy of Ulcerative Colitis

Katz

2002

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

The bewildering array of medications in the therapy of inflammatory bowel disease (IBD) often confounds the clinician in the choice of specific agents regarding the balance between safety and efficacy. This review surveys and evaluates currently available IBD therapies as well as those used in clinical trials of ulcerative colitis. The primary purpose is to provide the busy clinician with a practical guide to the use of established and newly emerging medical therapies of IBD.

show abstract

Update in Medical Therapy of Ulcerative Colitis

Katz

2002

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Continous oral plus topical 5-ASA administration significantly modifies the clinical course of ulcerative colitis

Cited by 1 publication

References 0 publications

Update in Medical Therapy of Ulcerative Colitis

Update in Medical Therapy of Ulcerative Colitis

Contact Info

Product

Resources

About